Browse Related Topics For:

ANDA

216
Pharmaceutical Industry
210
Patents
186
Pharmaceutical Patents
173
Generic Drugs
172
Patent Litigation
165
Patent Infringement
96
FDA
83
Hatch-Waxman
81
Prescription Drugs
41
Mylan Pharmaceuticals
37
Reverse Payment Settlement Agreements
36
SCOTUS
34
FTC
33
Actavis Inc.
31
FTC v Actavis
29
Biotechnology
29
Teva Pharmaceuticals
27
Obviousness
24
Personal Jurisdiction
23
Apotex
21
Merck
20
Patent Invalidity
20
Patent-in-Suit
17
AstraZeneca
17
Prior Art
16
Claim Construction
15
Eli Lilly
15
Infringement
15
Watson Pharmaceuticals
14
Pay-For-Delay
14
Sandoz
13
Antitrust Litigation
13
Orange Book
12
Jurisdiction
12
Noninfringement
12
Novartis
11
Appeals
11
BPCIA
11
Cephalon
11
Declaratory Judgments
11
FDCA
11
Labeling
11
Motion to Dismiss
10
Inter Partes Review Proceedings
10
On-Sale Bar
10
Patent Trial and Appeal Board
10
Pfizer
10
Popular
9
Biosimilars
9
DaimlerChrysler v Bauman
9
FDA Approval
9
Hospira
9
Par Pharmaceutical
9
Patent Applications
9
Sherman Act
9
USPTO
8
Allergan Inc
8
Manufacturers
8
Safe Harbors
8
Summary Judgment
7
America Invents Act
7
Amgen
7
Generic
7
Healthcare
7
Induced Infringement
7
Janssen Pharmaceuticals
7
Roxane Laboratories
7
Specific Jurisdiction
6
Biologics
6
Corporate Counsel
6
DaimlerAG
6
Gilead Sciences
6
Medical Devices
6
Orphan Drugs
6
Prometheus
6
Written Descriptions
5
AbbVie
5
Anti-Competitive
5
Bayer
5
Doctrine of Equivalents
5
GlaxoSmithKline
5
Minimum Contacts
5
Otsuka Pharmaceutical
5
Patent-Eligible Subject Matter
5
Rule-of-Reason Analysis
5
Warner Chilcott
4
Boehringer
4
Commercial Marketing
4
Estoppel
4
Exclusivity
4
Federal Rule 12(b)(6)
4
General Jurisdiction
4
Intellectual Property Litigation
4
Life Sciences
4
Medicare
4
No-AG Agreement
4
Settlement
4
Spectrum
4
Standing
4
Suppliers
3
Affordable Care Act
3
Antitrust Provisions
3
Antitrust Violations
3
Bristol-Myers Squibb
3
Class Action
3
Classen Immunotherapies
3
CLS Bank v Alice Corp
3
Disgorgement
3
Draft Guidance
3
Elan Pharmaceuticals
3
Enablement Inquiries
3
Endo Pharmaceuticals
3
Failure To Warn
3
Forest Laboratories
3
Forum Shopping
3
Fresenius
3
HHS
3
Jazz Pharmaceuticals
3
Legislative Agendas
3
Medicare Modernization Act
3
Method Claims
3
Product Labels
3
RanBaxy
3
Real Party in Interest
3
Reversal
3
Sandoz v Amgen
3
SmithKline Beecham
3
Takeda Pharmaceuticals
3
Third-Party Relationships
3
Unfair Competition
2
Allergan v Sandoz
2
Amarin
2
Antitrust Investigations
2
Bausch & Lomb
2
Biopharmaceutical
2
Cadence Pharmaceuticals Inc.
2
Cadillac Tax
2
CAFC
2
Cancer
2
Certiorari
2
Chevron Deference
2
Citizen Petitions
2
Clinical Trials
2
CMS
2
Counterclaims
2
De Novo Standard of Review
2
Disclosure Requirements
2
Dismissals
2
DSCSA
2
En Banc Review
2
Extortion
2
FDA Warning Letters
2
Federal Budget
2
First Amendment
2
Forum
2
Forum Selection
2
Genzyme
2
Health Care Providers
2
Health Insurance
2
Indefiniteness
2
Injunctions
2
Inter Partes Reexamination
2
Interlocutory Appeals
2
IRS
2
ITC
2
Lanham Act
2
Limelight v Akamai
2
Malicious Prosecution
2
Medicaid
2
Motion To Stay
2
New Guidance
2
Notice Requirements
2
Nunc Pro Tunc
2
Obama Administration
2
Off-Label Promotion
2
OIG
2
Out-of-State Companies
2
OxyContin
2
Patent Dance
2
Patients
2
Permanent Injunctions
2
Pleading Standards
2
Pleadings
2
PLIVA v Mensing
2
Preemption
2
Preliminary Injunctions
2
Product Exclusivity
2
Product Hopping
2
Proposed Legislation
2
Putative Class Actions
2
Reissue Patents
2
REMS
2
Reporting Requirements
2
Reverse Payments
2
Rulemaking Process
2
Sanofi-Aventis
2
Subject Matter Jurisdiction
2
Trademarks
2
TRO
2
Vaccinations
2
Young Lawyers
1
Abbott Laboratories
1
aBLA
1
Abstract Ideas
1
ACOs
1
Acquisitions
1
Administrative Procedure Act
1
Advertising
1
AHRQ
1
Amazon
1
Ambiguous
1
Anti-SLAPP
1
Antibiotics
1
Antitrust Conspiracies
1
Antitrust Injuries
1
App Developers
1
Arbitration
1
Arbitration Agreements
1
Article III
1
Assignments
1
Assignor Estoppel
1
Attorney-Client Privilege
1
Automatic Stay
1
Bifurcation
1
Bipolar Disorder
1
Brand
1
Broadest Reasonable Interpretation Standard
1
Burden of Proof
1
CA Supreme Court
1
Cal Code of Civil Procedure
1
Caronia
1
Carve Out Provisions
1
CDC
1
Certifications
1
CGMP
1
CHIP
1
Cipro
1
Cisco v CommilUSA
1
Civil Monetary Penalty
1
Claim Preclusion
1
Claims Limitations Period
1
Class Certification
1
Clear and Convincing Evidence
1
Clear Error Standard
1
Clinical Laboratory Testing
1
Combination Products
1
Comment Period
1
Competition
1
Complex Litigation
1
Compliance
1
Confidentiality Agreements
1
Consent
1
Consent Order
1
Continuing Resolution
1
Contract Disputes
1
Contract Drafting
1
Copyright
1
Covered Business Method Patents
1
Cuozzo Speed Technologies v Lee
1
Daiichi Sankyo
1
Damages
1
Data Protection
1
Data Security
1
Debt Ceiling
1
Delaware General Corporation Law
1
Dell
1
Direct Infringement
1
Direct Purchasers
1
Disclosure
1
Discovery
1
Dispute Resolution
1
Divided Infringement
1
DOJ
1
Drug Pricing
1
Due Process
1
Duty to Deal
1
E-Filing
1
Electronic Records
1
Employer Mandates
1
Exemptions
1
Expert Testimony
1
Expert Witness
1
Failure To State A Claim
1
Fair Market Value
1
False Advertising
1
False Claims Act (FCA)
1
FDASIA
1
Federal Civil Penalties Inflation Adjustment Act Improvements Act of 2015
1
Federal Jurisdiction
1
Federal Rules of Civil Procedure
1
Foreign Corporations
1
Foreign Defendants
1
Forum Non Conveniens
1
Genentech
1
Good Clinical Practices
1
Good Faith
1
Goodyear
1
Government Investigations
1
Hart-Scott-Rodino Act
1
Health Information Technologies
1
Hedge Funds
1
Hoffman LaRoche
1
Home Healthcare Workers
1
HRSA
1
Imminent Harm
1
Implied Consent
1
Individual Mandate
1
Information Reports
1
Innovation Act
1
Integra
1
International Arbitration
1
Inventors
1
IP Assignment Agreements
1
John Boehner
1
Joint Venture
1
Judge Stark
1
Judgment on the Pleadings
1
Justiciable Controversy
1
Laches
1
Leave to Amend
1
License Agreements
1
Licensing Rules
1
Likelihood of Success
1
Lipitor
1
Litigation Privilege
1
Long Arm Statute
1
Manufacturing Facilities
1
Marketing
1
Markman Hearing
1
Martin Shkreli
1
Mayo v. Prometheus
1
Meaningful Use
1
Means-Plus-Function
1
Medicaid Expansion
1
Medical Device Tax
1
Medical Foods
1
Medicare Prescription Drug Improvement and Modernization Act (MMA)
1
Mensing
1
Mergers
1
Minimum Wage
1
Misbranding
1
Monopolization
1
Motion for Reconsideration
1
Motion to Amend
1
Motion to Transfer
1
New Trial
1
NIH
1
Nintendo
1
Noerr-Pennington Doctrine
1
Non-Compete Agreements
1
Non-Disclosure Agreement
1
Off-Label Use
1
Offsets
1
OTDP
1
Overpayment
1
PATENT Act
1
Patent Agent Privilege
1
Patent Ownership
1
Patent Prosecution
1
Patent Reform
1
Patent Term Extensions
1
Patent Trolls
1
Patent Validity
1
Patent-Misuse
1
Patient Safety
1
Pending Legislation
1
Personalized Medicine
1
Petition For Rehearing
1
Pharmacies
1
Physician Medicare Reimbursements
1
Physician SGR Formula
1
Physician-Assisted Suicide
1
Physicians
1
Policies and Procedures
1
Post-Grant Review
1
Premerger Notifications
1
Presumption of Validity
1
Proposed Regulation
1
Public Health Insurance Marketplace
1
Public Health Service Act
1
Public Meetings
1
Rebates
1
Registration Requirement
1
Remand
1
Research and Development
1
Research Tools
1
Restraining Orders
1
Restrictive Covenants
1
Risk Management
1
Risk-Based Approaches
1
Royalties
1
Sales Contracts
1
Sanctions
1
SEC
1
Secretary of HHS
1
Section 337
1
Section 340B
1
Set-Asides
1
Sham Citizen Petitions
1
Sham Litigation Exception
1
Shire Development v Watson
1
SNDAs
1
Software Patents
1
Split of Authority
1
Standard Essential Patents
1
Standard of Proof
1
Startups
1
State Law Tort Claims
1
Subsidiaries
1
Tax Liability
1
The Common Rule
1
Threshold Requirements
1
Tolling
1
Trade Secrets
1
Trademark Infringement
1
Trans-Pacific Partnership
1
Transfer of Title
1
Unclean Hands
1
Universal Health Services Inc v United States ex rel Escobar
1
Validity
1
Wage and Hour
1
Warning Labels
1
WIPO
1
Work Product Privilege
1
Wyeth